<!DOCTYPE html>
<html>
  <head>
    <title>Hormone replacement therapy</title>
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta charset="utf-8">
    <!-- Bootstrap -->
    <link href="//netdna.bootstrapcdn.com/bootswatch/3.2.0/flatly/bootstrap.min.css" rel="stylesheet" media="screen">
    <link href="/css/site.css" rel="stylesheet" media="screen">
    <link href="/css/syntax.css" rel="stylesheet" media="screen">

    <!-- HTML5 Shim and Respond.js IE8 support of HTML5 elements and media queries -->
    <!-- WARNING: Respond.js doesn't work if you view the page via file:// -->
    <!--[if lt IE 9]>
      <script src="https://oss.maxcdn.com/libs/html5shiv/3.7.0/html5shiv.js"></script>
      <script src="https://oss.maxcdn.com/libs/respond.js/1.3.0/respond.min.js"></script>
    <![endif]-->
<script>
  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
  })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

  ga('create', 'UA-48968311-4', 'jandecaluwe.com');
  ga('send', 'pageview');

</script>
  </head>

  <body>

    <!-- Fixed navbar -->
    <div class="navbar navbar-default navbar-fixed-top">
      <div class="container">
        <div class="navbar-header">
          <button type="button" class="navbar-toggle" data-toggle="collapse" data-target=".navbar-collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </button>
          <a class="navbar-brand" href="/">Rory’s notes</a>
        </div>
        <div class="navbar-collapse collapse">

          <ul class="nav navbar-nav navbar-left">
 
          </ul>

          <ul class="nav navbar-nav navbar-right">
            <li class="active"><a href="/notes/">notes</a></li>
          </ul>

        </div><!--/.nav-collapse -->
      </div>
    </div>


<div class="container">

  <ol class="breadcrumb">
    <li><a href="/">Home</a></li>
      <li><a href="/notes/">notes</a></li>
      <li><a href="/notes/womens_health/">womens_health</a></li>
      <li class="active">Hormone replacement therapy</li>
  </ol>

  <div class="page-header">
 
    <h1>Hormone replacement therapy</h1>
  </div>

  <div class="row">

    <div class="col-md-3" role="navigation"> 
 
      <div class="sidebar" data-spy="affix" data-offset-top="80" data-offset-bottom="60">
        <div class="well">
          <a href="#"><strong>Hormone replacement therapy</strong></a>
          <div class="toc">
<ul>
<li><a href="#summary">Summary</a><ul>
<li><a href="#urogential-symptoms">Urogential symptoms</a></li>
<li><a href="#hysterectomy">Hysterectomy</a></li>
<li><a href="#intact-uterus">Intact uterus</a><ul>
<li><a href="#premature-menopause-40">Premature menopause (\&lt;40)</a></li>
<li><a href="#menopausal-transition">Menopausal transition</a></li>
</ul>
</li>
<li><a href="#post-menopausal">Post menopausal</a></li>
</ul>
</li>
<li><a href="#background">Background</a></li>
<li><a href="#risk-benefit">Risk / Benefit</a><ul>
<li><a href="#combined-treatment">Combined treatment</a></li>
<li><a href="#oestrogen-only">Oestrogen only</a></li>
</ul>
</li>
<li><a href="#contraindications">Contraindications</a></li>
<li><a href="#indications">Indications</a></li>
<li><a href="#managementdosing">Management/dosing</a><ul>
<li><a href="#women-beginning-treatment">women beginning treatment</a></li>
<li><a href="#women-who-have-had-hysterecotmy">women who have had hysterecotmy</a></li>
<li><a href="#women-with-uterus">women with uterus</a></li>
<li><a href="#perimenopausalrecent-menopause">perimenopausal/recent menopause</a></li>
<li><a href="#postmenopausal-for-1yr">postmenopausal for ≥1yr</a></li>
<li><a href="#adverse-effects">adverse effects</a></li>
</ul>
</li>
<li><a href="#monitoring">Monitoring</a></li>
<li><a href="#discontinue">Discontinue</a></li>
<li><a href="#alternatives">alternatives</a></li>
<li><a href="#risksbenefits">Risks/benefits</a><ul>
<li><a href="#osteoporosis">Osteoporosis</a></li>
<li><a href="#coronary-heart-disease">Coronary heart disease</a></li>
<li><a href="#stroke">Stroke</a></li>
<li><a href="#dementia">Dementia</a></li>
<li><a href="#ovarian-cancer">Ovarian cancer</a></li>
<li><a href="#vte">VTE</a></li>
<li><a href="#breast-cancer">breast cancer</a></li>
<li><a href="#-exercise">- Exercise</a></li>
</ul>
</li>
</ul>
</div>

        </div>
      </div>
    </div>
 
    <div class="content">
      <div class="col-md-6" role="main">
        <p><code>(2008 BPAC)</code></p>
<h3 id="summary">Summary</h3>
<h4 id="urogential-symptoms">Urogential symptoms</h4>
<ul>
<li>vaginal oestrogen</li>
</ul>
<h4 id="hysterectomy">Hysterectomy</h4>
<ul>
<li>continuous oestrogen</li>
</ul>
<h4 id="intact-uterus">Intact uterus</h4>
<h5 id="premature-menopause-40">Premature menopause (\&lt;40)</h5>
<ul>
<li>
<p>continue HRT until 50</p>
</li>
<li>
<p>low dose OCP or</p>
</li>
<li>
<p>cont oestrogen + cyclic/continuous progestin or </p>
</li>
<li>
<p>Tibolone</p>
</li>
</ul>
<h5 id="menopausal-transition">Menopausal transition</h5>
<ul>
<li>
<p>low dose COC </p>
</li>
<li>
<p>continuosu oestrogen + cyclic progestin 14d each cycle (d 15-28) + contraceptoin</p>
</li>
<li>
<p>continuous oestrogen + LNG releasing IUD</p>
</li>
</ul>
<h4 id="post-menopausal">Post menopausal</h4>
<ul>
<li>
<p>continuous oestrogen + continuous progestin </p>
</li>
<li>
<p>continuous oestrogen + cyclic progesting or LNG IUD</p>
</li>
</ul>
<h3 id="background">Background</h3>
<ul>
<li>
<p>10% women seek help from GP</p>
</li>
<li>
<p>HRT popular until 2002</p>
<ul>
<li>evidence emerge of signifant risks</li>
</ul>
</li>
<li>
<p>most effective treatment for symptoms of menopause</p>
</li>
</ul>
<h3 id="risk-benefit">Risk / Benefit</h3>
<ul>
<li>
<p>consider:</p>
<ul>
<li>
<p>treatment goals</p>
</li>
<li>
<p>benefits</p>
</li>
<li>
<p>risks</p>
</li>
</ul>
</li>
<li>
<p>factors to consider:</p>
<ul>
<li>
<p>time of menopause</p>
</li>
<li>
<p>impact of symptoms on QoL</p>
</li>
<li>
<p>Underlying risk of:</p>
<ul>
<li>
<p>CVD</p>
</li>
<li>
<p>Stroke</p>
</li>
<li>
<p>VTE</p>
</li>
<li>
<p>cancers</p>
</li>
<li>
<p>other conditions</p>
</li>
</ul>
</li>
<li>
<p>Suitability of other treatments</p>
</li>
</ul>
</li>
</ul>
<h5 id="combined-treatment">Combined treatment</h5>
<ul>
<li>
<p>risks</p>
<ul>
<li>
<p>breast ca</p>
</li>
<li>
<p>Coronary heart disease</p>
<ul>
<li>first year of use</li>
</ul>
</li>
<li>
<p>dementia and cognition</p>
<ul>
<li>>65yo</li>
</ul>
</li>
<li>
<p>gall bladder disease</p>
</li>
<li>
<p>stroke VTE</p>
</li>
<li>
<p>?ovarian cancer</p>
</li>
</ul>
</li>
<li>
<p>benefits</p>
<ul>
<li>
<p>vasomotor</p>
</li>
<li>
<p>urogenital</p>
</li>
<li>
<p>sleep disturbance</p>
</li>
<li>
<p>osteoporotic #</p>
</li>
<li>
<p>colorectal cancer</p>
</li>
<li>
<p>?DM</p>
</li>
</ul>
</li>
</ul>
<h5 id="oestrogen-only">Oestrogen only</h5>
<ul>
<li>
<p>Risks</p>
<ul>
<li>
<p>endometrial cancer (if uterus present)</p>
</li>
<li>
<p>gall bladder disease</p>
</li>
<li>
<p>stroke</p>
</li>
<li>
<p>VTE</p>
</li>
<li>
<p>?ovarian</p>
</li>
</ul>
</li>
<li>
<p>Benefits</p>
<ul>
<li>
<p>as per Combined</p>
</li>
<li>
<p>?depression</p>
</li>
</ul>
</li>
</ul>
<h3 id="contraindications">Contraindications</h3>
<ul>
<li>
<p>previous breast cancer</p>
</li>
<li>
<p>previous or high risk of CV disease</p>
</li>
<li>
<p>previosu or high risk of VTE</p>
</li>
<li>
<p>Dementia</p>
</li>
</ul>
<blockquote>
<p>HRT not recommended for prevention of chronic illness</p>
</blockquote>
<h3 id="indications">Indications</h3>
<ul>
<li>
<p>vasomotor:</p>
<ul>
<li>
<p>hot flushes</p>
</li>
<li>
<p>night sweats</p>
</li>
<li>
<p>improvement may be seen within 4 weeks</p>
</li>
<li>
<p>short term use (1-2yrs) appropriate as flushes disappear within few years of menopause in about 2/5 women</p>
</li>
</ul>
</li>
<li>
<p>urogenital symptoms:</p>
<ul>
<li>
<p>dyness</p>
</li>
<li>
<p>soreness</p>
</li>
<li>
<p>dyspareunia</p>
</li>
<li>
<p>increase urinary frequency/urgency</p>
</li>
<li>
<p>occur in 50%</p>
</li>
<li>
<p>topical vaginal oestrogen may provide benefit </p>
</li>
<li>
<p>response can take several months</p>
</li>
<li>
<p>systemic absorption minimal</p>
</li>
</ul>
</li>
</ul>
<h3 id="managementdosing">Management/dosing</h3>
<blockquote>
<p>use lowest dose, for shortest duration possible</p>
</blockquote>
<h4 id="women-beginning-treatment">women beginning treatment</h4>
<ul>
<li>
<p>0.3mg conjugated oestrogen or </p>
</li>
<li>
<p>0.5-1.0mg 17-B-oestradiol or oestradiol valerate (low dose)</p>
</li>
</ul>
<h4 id="women-who-have-had-hysterecotmy">women who have had hysterecotmy</h4>
<ul>
<li>
<p>oestrogen only</p>
</li>
<li>
<p>continusous</p>
</li>
</ul>
<h4 id="women-with-uterus">women with uterus</h4>
<ul>
<li>
<p>add progestogen to protect endometrium</p>
<ul>
<li>
<p>oral</p>
</li>
<li>
<p>intrauterine system</p>
</li>
</ul>
</li>
<li>
<p>low dose prepacked regimens can be used initially</p>
</li>
</ul>
<h4 id="perimenopausalrecent-menopause">perimenopausal/recent menopause</h4>
<ul>
<li>
<p>combined sequential treatment</p>
<ul>
<li>oestrogen daily with progestogen 10-14 days/month</li>
</ul>
</li>
<li>
<p>oestrogen started on first day of menstrual bleed</p>
</li>
<li>
<p>progestogen 14 days later</p>
<ul>
<li>withdrawal bleeding should then starrt at time that next period would be expected</li>
</ul>
</li>
</ul>
<p>-</p>
<h4 id="postmenopausal-for-1yr">postmenopausal for ≥1yr</h4>
<ul>
<li>
<p>combined continuous treatment</p>
<ul>
<li>
<p>oestrogen and progestogen daily</p>
</li>
<li>
<p>may cause irregular bleeding in first 6-12 months of daily use</p>
</li>
</ul>
</li>
</ul>
<blockquote>
<p>women with premature menopause may have more severe symptoms == higher doses of HRT</p>
</blockquote>
<h4 id="adverse-effects">adverse effects</h4>
<ul>
<li>
<p>irregular bleeding = combined regimes</p>
</li>
<li>
<p>nausea</p>
</li>
<li>
<p>breast tenderness</p>
</li>
<li>
<p>symptoms decrease over time</p>
</li>
<li>
<p>lowering dose = reduce these effects</p>
</li>
</ul>
<h3 id="monitoring">Monitoring</h3>
<ul>
<li>
<p>before treatment</p>
<ul>
<li>
<p>cardiovascular risk assessment</p>
</li>
<li>
<p>up to date breast and cervical screening</p>
</li>
<li>
<p>DEXA = case-case</p>
</li>
<li>
<p>Endometrial investigation not usually required</p>
<ul>
<li>unless intermenstrual bleeding or bleeding after 1-2 years no periods</li>
</ul>
</li>
</ul>
</li>
<li>
<p>during treatment</p>
<ul>
<li>
<p>BP</p>
</li>
<li>
<p>others done as indicated</p>
</li>
</ul>
</li>
</ul>
<h3 id="discontinue">Discontinue</h3>
<ul>
<li>
<p>75% women stop HRT 2 years; usually without seeing GP</p>
</li>
<li>
<p>attempted withdrawal appropriate after 1-2yrs</p>
<ul>
<li>see if symptoms resolved</li>
</ul>
</li>
<li>
<p>50% recurring if treatment stopped</p>
</li>
<li>
<p>stop abruptly vs taper</p>
<ul>
<li>
<p>arguments….</p>
</li>
<li>
<p>give women choice</p>
</li>
</ul>
</li>
<li>
<p>if return of symptoms:</p>
<ul>
<li>
<p>restart</p>
</li>
<li>
<p>dose slowly decreased over next 3-6 months</p>
</li>
<li>
<p>non hormonal</p>
</li>
</ul>
</li>
</ul>
<h3 id="alternatives">alternatives</h3>
<ul>
<li>
<p>Lifestyle</p>
<h4 id="-exercise">- Exercise</h4>
<ul>
<li>
<p>weight managment</p>
</li>
<li>
<p>smoking</p>
</li>
<li>
<p>stop caffeine/etoh</p>
</li>
</ul>
</li>
<li>
<p>SSRI</p>
</li>
<li>
<p>Tibolone</p>
<ul>
<li>
<p>synthetic steroid</p>
<ul>
<li>
<p>weak oestrogenic </p>
</li>
<li>
<p>progestogenic</p>
</li>
<li>
<p>androgenic</p>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p>Soy produces</p>
</li>
<li>
<p>evening primrose oil</p>
</li>
</ul>
<h3 id="risksbenefits">Risks/benefits</h3>
<h4 id="osteoporosis">Osteoporosis</h4>
<ul>
<li>
<p>reducing risk osteoporotic # and increaseing bone density</p>
</li>
<li>
<p>life long use required to prevent bone #</p>
</li>
<li>
<p>not first line for women with B low BMD</p>
</li>
<li>
<p>Hazard:</p>
<ul>
<li>
<p>0.76 (0.69-0.85) combined</p>
</li>
<li>
<p>0.70 (0.63 -0.79) oestrogen only</p>
</li>
</ul>
</li>
</ul>
<h4 id="coronary-heart-disease">Coronary heart disease</h4>
<ul>
<li>
<p>conflicting evidence</p>
</li>
<li>
<p>timing hypothesis</p>
</li>
<li>
<p>increase in first year of treatment</p>
</li>
<li>
<p>most were over 64 at time of trial entry</p>
</li>
<li>
<p>Hazard</p>
<ul>
<li>
<p>1.24 combined (1.00-1.54)</p>
</li>
<li>
<p>1.92 first year (1.09-3.01)</p>
</li>
<li>
<p>Oestrogen only (0.95-1.16)</p>
</li>
</ul>
</li>
</ul>
<p>-</p>
<h4 id="stroke">Stroke</h4>
<ul>
<li>
<p>increased</p>
</li>
<li>
<p>absolute risk = lower for women under 60 in whom menopause occured within previous 5 years</p>
</li>
<li>
<p>Hazard</p>
<ul>
<li>
<p>combined 1.41 (1.07 - 1.85)</p>
</li>
<li>
<p>Oestrogen 1.39 (1.10-1.77)</p>
</li>
</ul>
</li>
</ul>
<h4 id="dementia">Dementia</h4>
<ul>
<li>
<p>doesn’t prevent cognitive decline</p>
</li>
<li>
<p>2 fold increase in >75 if taking</p>
</li>
</ul>
<h4 id="ovarian-cancer">Ovarian cancer</h4>
<ul>
<li>
<p>evidence conflicting</p>
</li>
<li>
<p>HRT - esp oestrogen only</p>
<ul>
<li>
<p>increased risk</p>
</li>
<li>
<p>1.28 </p>
</li>
</ul>
</li>
</ul>
<h4 id="vte">VTE</h4>
<ul>
<li>
<p>signifiant increase in risk</p>
</li>
<li>
<p>greatst first 102 years of treatment</p>
</li>
<li>
<p>absolute risk small - baseline = 1.7 events per 1000</p>
<ul>
<li>1.95 combined, 1.47 oestrogen</li>
</ul>
</li>
</ul>
<h4 id="breast-cancer">breast cancer</h4>
<ul>
<li>
<p>increases risk of diagnosis/recurrence</p>
</li>
<li>
<p>oestrogen only doesn’t appear to increase risk</p>
</li>
<li>
<p>1.24 for combined (1.01-1.54)</p>
</li>
</ul>
<p>end</p>
      </div>
    </div>

  </div>
    

    <div class="footer">
        <p>Website powered by <a href="http://urubu.jandecaluwe.com">Urubu</a></p>
    </div>


</div> 


    <!-- jQuery (necessary for Bootstrap's JavaScript plugins) -->
    <script src="https://code.jquery.com/jquery.js"></script>
    <!-- Include all compiled plugins (below), or include individual files as needed -->
    <script src="//netdna.bootstrapcdn.com/bootstrap/3.2.0/js/bootstrap.min.js"></script>

  </body>
</html>
